Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
18 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kyorin-and-cyrano-therapeutics-enter-into-an-option-agreement-for-cyr-064-for-the-treatment-of-post-viral-loss-of-smell-in-japan-302378067.html
04 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cyrano-therapeutics-announces-the-launch-of-an-investigator-initiated-clinical-study-evaluating-cyr-064-for-the-loss-of-smell-hyposmia-in-parkinsons-disease-patients-302367016.html
16 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cyrano-therapeutics-secures-9-0-million-series-b-financing-to-advance-clinical-development-of-cyr-064-for-treatment-of-post-viral-smell-loss-302031744.html
12 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cyrano-therapeutics-enrolls-first-patient-in-phase-2-trial-of-cyr-064-for-post-viral-smell-loss-hyposmia-301954527.html
19 Jan 2023
// CLINICAL TRIALS ARENA
https://www.clinicaltrialsarena.com/news/cyrano-trial-nasal-spray-therapy-hyposmia/
09 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/cyrano-therapeutics-announces-the-appointment-of-john-kollins-to-its-board-of-directors-301420237.html
ABOUT THIS PAGE